International Patent: A NEW QUALIQUANTITATIVE BENEFIT/RISK ASSESSMENT METHOD SUITABLE FOR THE PHYSIOLOGICAL ACTIVITY OF NATURAL MATRICES-BASED THERAPEUTIC OR BENEFICIAL PRODUCTS WITH RESPECT TO THAT OF OTHER PRODUCTS WITH PHARMACOLOGICAL OR NUTRACEUTICAL ACTIVITY BASED ON SYNTHETIC MOLECULES

GENEVA, Aug. 7 -- BIOS-THERAPY, PHYSIOLOGICAL SYSTEMS FOR HEALTH S.P.A. filed a patent application (IB2025/053888) for “A NEW QUALIQUANTITATIVE BENEFIT/RISK ASSESSMENT METHOD SUITABLE FOR THE PHYSIOLOGICAL ACTIVITY OF NATURAL MATRICES-BASED THERAPEUTIC OR BENEFICIAL PRODUCTS WITH RESPECT TO THAT OF OTHER PRODUCTS WITH PHARMACOLOGICAL OR NUTRACEUTICAL ACTIVITY BASED ON SYNTHETIC MOLECULES”. With publication no. WO/2026/162982, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: G16B 5/00

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curat...